ATE168562T1 - Parathyroidhormon enthaltene emulsion zur nasalen verabreichung - Google Patents

Parathyroidhormon enthaltene emulsion zur nasalen verabreichung

Info

Publication number
ATE168562T1
ATE168562T1 AT92919966T AT92919966T ATE168562T1 AT E168562 T1 ATE168562 T1 AT E168562T1 AT 92919966 T AT92919966 T AT 92919966T AT 92919966 T AT92919966 T AT 92919966T AT E168562 T1 ATE168562 T1 AT E168562T1
Authority
AT
Austria
Prior art keywords
parathyroid hormone
emulsion containing
nasal administration
integer
containing parathyroid
Prior art date
Application number
AT92919966T
Other languages
English (en)
Inventor
Nakayuki Yamamoto
Michihiko Sugimoto
Seiki Morimoto
Hideo Sakakibara
Masaru Saita
Yuji Shimozono
Takafumi Manako
Original Assignee
Asahi Chemical Ind
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind, Hisamitsu Pharmaceutical Co filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE168562T1 publication Critical patent/ATE168562T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92919966T 1991-09-17 1992-09-16 Parathyroidhormon enthaltene emulsion zur nasalen verabreichung ATE168562T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03236193A JP3090353B2 (ja) 1991-09-17 1991-09-17 パラチロイドホルモン類含有経鼻投与用乳剤

Publications (1)

Publication Number Publication Date
ATE168562T1 true ATE168562T1 (de) 1998-08-15

Family

ID=16997158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92919966T ATE168562T1 (de) 1991-09-17 1992-09-16 Parathyroidhormon enthaltene emulsion zur nasalen verabreichung

Country Status (9)

Country Link
US (1) US5407911A (de)
EP (1) EP0610502B1 (de)
JP (1) JP3090353B2 (de)
KR (1) KR0129865B1 (de)
AT (1) ATE168562T1 (de)
AU (1) AU662168B2 (de)
CA (1) CA2118655C (de)
DE (1) DE69226370T2 (de)
WO (1) WO1993005805A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255723B (it) * 1992-10-09 1995-11-13 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
AU686149B2 (en) * 1993-04-19 1998-02-05 Institute For Advanced Skin Research Inc. Microemulsion preparation containing difficultly absorbable substance
ES2171459T3 (es) * 1993-07-30 2002-09-16 Teijin Ltd Polvo para administracion nasal de farmaco peptidico o proteinaceo.
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
US8580290B2 (en) * 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
AU2002363412A1 (en) * 2001-11-05 2003-05-19 Eli Lilly And Company Method for improving stability of a bone-connecting implant
EP1380630A3 (de) * 2002-07-11 2004-01-28 Herbal Apothecary Limited Netz- und Trennungsmittel für Kohlenwasserstoffe.
US7329725B1 (en) 2003-10-29 2008-02-12 Nastech Pharmaceutical Company Inc. Phage displayed Trp cage ligands
US20060052306A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. GRAS composition for enhanced mucosal delivery of parathyroid hormone
US20060189533A1 (en) * 2004-05-10 2006-08-24 Nastech Pharmaceutical Company Inc. Stable pharmaceutical dosage forms of teriparatide
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) * 2006-07-07 2008-05-22 Nastech Pharmaceutical Company Inc. Pth formulations for intranasal delivery
EP1961765A1 (de) * 2006-12-08 2008-08-27 Zealand Pharma A/S Verkürzte PTH-Peptide mit zyklischer Konformation
US9687559B2 (en) * 2008-03-19 2017-06-27 The Board Of Regents Of The University Of Oklahoma Heparosan polymers and methods of making and using same for the enhancement of therapeutics
US9925209B2 (en) 2008-03-19 2018-03-27 The Board Of Regents Of The University Of Oklahoma Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
PL2831237T3 (pl) 2012-03-30 2018-06-29 The Board Of Regents Of The University Of Oklahoma Polimery heparosanu o wysokiej masie cząsteczkowej i sposoby ich wytwarzania i zastosowania
WO2020090174A1 (ja) * 2018-10-29 2020-05-07 旭化成ファーマ株式会社 週２回の頻度でテリパラチド又はその塩を投与することを特徴とする、骨粗鬆症の予防又は治療方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
JPH01233230A (ja) * 1988-03-14 1989-09-19 Minofuaagen Seiyaku Honpo:Goushi 経粘膜吸収促進剤及びこれを用いた点鼻剤
JP2720899B2 (ja) * 1988-07-15 1998-03-04 合資会社ミノファーゲン製薬本舗 経粘膜吸収促進剤及びこれを用いた経鼻投与剤
JP2911496B2 (ja) * 1989-09-11 1999-06-23 帝國製薬株式会社 生理活性ポリペプチド含有高吸収性経膣剤
JPH0446129A (ja) * 1990-06-12 1992-02-17 Asahi Chem Ind Co Ltd 新規なリポソーム形成助剤
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9020544D0 (en) 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE69226370D1 (de) 1998-08-27
WO1993005805A1 (fr) 1993-04-01
JPH0570367A (ja) 1993-03-23
CA2118655A1 (en) 1993-04-01
AU662168B2 (en) 1995-08-24
EP0610502A4 (de) 1996-02-28
DE69226370T2 (de) 1999-04-22
EP0610502A1 (de) 1994-08-17
JP3090353B2 (ja) 2000-09-18
CA2118655C (en) 1997-08-19
EP0610502B1 (de) 1998-07-22
AU2584392A (en) 1993-04-27
KR0129865B1 (ko) 1998-04-09
US5407911A (en) 1995-04-18

Similar Documents

Publication Publication Date Title
ATE168562T1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
MX9304300A (es) Composiciones herbicidas.
KR890016966A (ko) 신규 항바이러스제
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
IE790652L (en) Imidazole derivatives
DE68904792D1 (de) Biozide zusammensetzung.
DE69100436D1 (de) Kalzitonin enthaltende emulsion zur nasalen verabreichung.
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
FI941399A0 (fi) Sparfloksasiiniliuos, sen valmistus ja sitä sisältävä suola
ZA921341B (en) 4-((2-benzothiazolyl)methylamino)-a-(3,4-difluorophenoxy) methyl)-1-piperidineethanol.
MX9206930A (es) Nuevos compuestos
DK390384A (da) Midler med antimikrobiel virkning indeholdende derivater af benzoesyre og deres anvendelse som desinficerende laegemidler eller konserveringsmidler
DK0548635T3 (da) Farmaceutisk præparat af Roxindol eller Carmoxirol med foropkvældet stivelse
KR840005801A (ko) 균질성 액상 조성물
HUT48259A (en) Herbicide compositions containing new macrolide active components, and process for producing new macrolide compounds and pharmaceutical compositions containing them as active components
KR900016144A (ko) 4-이미다졸린 유도체
FR2674436B1 (fr) Nouvelle utilisation de sterouides 4,9,11-trieniques dans des compositions destinees a l'administration chez la dinde.
ES2118340T3 (es) Nuevos derivados de benzo-espiro-alquenos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AU560610B2 (en) Iodophor disinfectants
EP0653207A4 (de) Aids-virus-infektion hemmende zusammensetzung.
KR920019734A (ko) 페닐술포닐알칸산 화합물
KR860002498A (ko) 1,4-디하이드로피리딘 유도체의 약학조성물
JPS5732209A (en) Herbicidal composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties